Addex Therapeutics Ltd (ADXN) NASDAQ
6.27
-0.38(-5.71%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
6.27
-0.38(-5.71%)
Currency In USD
| Market Cap | 5.73M |
| Enterprise Value | 4.12M |
| P/E Ratio | -0.97 |
| PEG Ratio | 0.01 |
| Price/Sales Ratio | 45.67 |
| Price/Book Ratio | 1.38 |
| Enterprise/Revenue | 35.19 |
| Enterprise/EBITDA | -0.93 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | -43.98 |
| Operating Margin | -18.4 |
| Return On Assets | -1.06 |
| Return On Equity | -1.03 |
| Revenue | 29,972 |
| Revenue/Share | 0 |
| Gross Profit | 29,972 |
| EBITDA | -6.83M |
| Net Income | -6.73M |
| Diluted EPS | -6.88 |
| Total Cash | 1.64M |
| Total Cash/Share | 0.01 |
| Total Debt | 34,727 |
| Total Debt/Equity | 0.01 |
| Current Ratio | 1.4 |
| Book Value Per Share | 0.03 |
| 52-Week Change | -22.5 |
| 52-Week High | 12.05 |
| 52-Week Low | 5.41 |
| Moving Average 50 Days | 6.67 |
| Moving Average 200 Days | 7.84 |
| Average Volume | 3,792 |
| Shares Outstanding | 720,833 |
| % Held by Institutions | 6.21 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:20 |
| Last Split Date | October 23, 2023 |